argenx SE reported 1.13M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
AstraZeneca 303M 126M Jun/2025
Galapagos EUR 780K 49.34M Mar/2025
Genmab DKK 9M 4M Jun/2025
GlaxoSmithKline 184M 22M Jun/2025
GRIFOLS EUR 202.71M 94.07M Jun/2024
Hikma Pharmaceutical 22M 9M Jun/2024
Qiagen NV USD 7.6M 311K Jun/2025
UCB 108M 16M Dec/2024